Tag Archives: Chuck Grassley

Senators seek probe of Allergan’s patent sale to Mohawk Tribe; could Tesla do the same with its battery patents?

The News: Four senators are demanding an investigation of Allergan PLC’s (Dublin IRL) first-of-a-kind patent deal with the Saint Regis Mohawk Tribe, alleging the move to protect Restasis is another… Read more »

GOP healthcare bill heads to Senate where fate far from certain

The News: The US House of Representatives on Thursday (May 4, 2017) voted 217 to 213 in favor of proposed legislation that would repeal and replace parts of the Affordable Care Act (ACA), signed into… Read more »

Marathon’s defense of pricey orphan drug getting spotlight in Congress; running a marathon is far easier, and a lot cheaper

Steve’s Take: Marathon Pharmaceuticals LLC (Northbrook IL) caught my attention last month at the inception of an outcry when the company first announced the $89,000 price tag for its newly… Read more »

Mylan’s EpiPen faces competition from Kaleo Pharma; just what the doctor ordered

Privately held drugmaker Kaleo Inc. (Richmond VA), the main competitor to Mylan NV’s (Amsterdam) EpiPen, announced plans on Wednesday (October 26, 2016) for a US relaunch of its Auvi-Q injector… Read more »

Tenet to Pay $553 Million to Settle Kickback Allegations; Culture of Corruption Dates Back Decades

Tenet Healthcare Corp. (Dallas TX) and two of its Atlanta subsidiaries have agreed to pay more than $513 million to resolve criminal and civil claims accusing the chain of paying… Read more »

Mylan Agrees to $465 Million EpiPen Settlement with US; But the Matter is Far From Over

Mylan NV (Amsterdam) will pay the US government $465 million in a swift settlement over how the drugmaker charged Medicaid for its allergy shot EpiPen, according to Bloomberg News. The… Read more »

Painted as the Latest Pharma Scoundrel, Mylan’s CEO Bresch Isn’t Buying It; She’s Got a Point, Maybe

Last week Mylan pharmaceuticals CEO Heather Bresch seemingly attained a status of villainy synonymous with Lance Armstrong and, more recently, Ryan Lochte, with news stories of its fourfold price increase… Read more »

Mylan to Reduce Cost of EpiPen as Pressure Mounts; Not All Patients to Benefit

Mylan NV (Amsterdam) on Thursday took some steps to alleviate patients’ cost burden for its $600 EpiPen emergency allergy shots following pressure from politicians including presidential candidate Hillary Clinton, who… Read more »